Lilong Liu

7PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersTumour immunologyProteins and peptidesCancer diagnosisLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 15, 2026
1-Hydroxypyrene Promotes Bladder Cancer Progression and Tumor-Associated Immunosuppression via MIF.

|Aug 13, 2026
Integrative multi-omics analysis identifies SMIM24 as a favorable prognostic biomarker in clear cell renal cell carcinoma.

|Jun 02, 2026
LGALS1-CD276 Paracrine axis between tumor and endothelial cells promotes tumor angiogenesis and progression in bladder cancer.

|Apr 03, 2026
Extracellular and Membrane Protein: Structure, Biological Functions, Diseases, and an Emerging Modality for Drug Discovery.

Mengqing Zhao, Wenhao Yin, Jianjian Han

|Sep 10, 2025
An evaluation of the tumor microenvironment through CALR, IL1R1, IFNB1, and IFNG to assess prognosis and immunotherapy response in bladder cancer patients.

Lilong Liu, Zhenghao Liu, Lei Fan

|Aug 27, 2025
Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation.

Yiheng Dai, Lilong Liu, Yongbo Luo

Pageof 2

Frequent Collaborators

3 joint publications

Ke Chen

2 joint publications

Yiting Liu

2 joint publications

Yuhong Ding

1 joint publications

Yiheng Dai